GO
Loading...

Enter multiple symbols separated by commas

Mergers and Acquisitions Acquisitions

More

  • Apple-Beats 'huge culture clash': Strategist Friday, 9 May 2014 | 3:30 PM ET
    Apple-Beats 'huge culture clash': Strategist

    Max Wolff, Citizen V.C. chief economist; Yukari Kane, author of "Haunted Empire: Apple After Steve Jobs"; and David Nelson, Belpointe Asset Management.

  • Beats could be biggest Apple buy Friday, 9 May 2014 | 3:26 PM ET
    Beats could be biggest Apple buy

    A look at Apple's could-be deal with Beats Electronics, with CNBC's Morgan Brennan.

  • Hip hop millionaires Friday, 9 May 2014 | 2:52 PM ET
    Hip hop millionaires

    CNBC's Robert Frank reports on the race to be hip hop's first billionaire.

  • Songza CEO says industry 'young' Friday, 9 May 2014 | 2:48 PM ET
    Songza CEO says industry 'young'

    Discussing competition in the music streaming space, and what a potential deal between Apple and Beats Electronics could mean for the industry, with Elias Roman, Songza co-founder & CEO.

  • Potential Apple-Beats deal Friday, 9 May 2014 | 1:19 PM ET
    Potential Apple-Beats deal

    CNBC has learned Apple is in talks to buy headphone maker Beats Electronics for $3.2 billion. CNBC contributor Natalie Morris, and Peter Kafka, Re/code senior editor, discuss.

  • What's the point of Apple/Beat deal? Friday, 9 May 2014 | 8:31 AM ET
    What's the point of Apple/Beat deal?

    It's a huge departure for Tim Cook, says Matthew Garrahan, Financial Times media editor, discussing Apple's rumored attempt to acquire Beat Electronics for $3.2 billion.

  • Employees at Pfizer Inc's U.S. research centers may want to dust off their resumes if the company's proposed acquisition of Britain's AstraZeneca comes to fruition.

  • GE in talks to buy Alstom: Report Thursday, 24 Apr 2014 | 6:09 AM ET
    GE in talks to buy Alstom: Report

    Nicholas Heyman, William Blair, discusses General Electric's possible acquisition of French train and power plant builder Alstom for more than $13 billion.

  • Einhorn's new course Tuesday, 22 Apr 2014 | 2:31 PM ET
    Einhorn's new course

    Sandy Villere, Villere Funds, shares his thoughts on Greenlight Capital's new stake in Conn's.

  • Eli Lilly acquires Novartis' animal health unit Tuesday, 22 Apr 2014 | 7:18 AM ET
    Eli Lilly acquires Novartis' animal health unit

    Eli Lilly Chairman & CEO John Lechleiter discusses his business' expansion of its animal health unit with the acquisition of Novartis' animal health business.

  • GlaxoSmithKline CEO: Widest portfolio of vaccines in world

    GlaxoSmithKline CEO Sir Andrew Witty, explains the large portfolio of vaccinations his company provides, and the value added from the company's acquisition of Novartis' vaccination business.

  • Novartis acquisition adds 'tremendous value' Tuesday, 22 Apr 2014 | 6:45 AM ET
    Novartis acquisition adds 'tremendous value'

    GlaxoSmithKline CEO Sir Andrew Witty, discusses the benefit to shareholders from his company's acquisition of Novartis' vaccination business, as well as its oncology unit.

  • PwC strikes deal to buy Booz Thursday, 3 Apr 2014 | 7:16 AM ET
    PwC strikes deal to buy Booz

    Bob Moritz, PricewaterhouseCoopers chairman and senior partner, discusses the company's plan to boost its consulting business by extending its global reach.

  • Marriott completes deal to acquire Protea Tuesday, 1 Apr 2014 | 8:16 AM ET
    Marriott completes deal to acquire Protea

    Arne Sorenson, CEO & president of Marriott International, discusses his company's acquisition of the largest hotel company in Africa.

  • How activist investors influence M&A Friday, 28 Mar 2014 | 8:16 AM ET
    How activist investors influence M&A

    Michael Carr, Goldman Sachs M&A group in the Americas, shares his thoughts on the role of activists in deal making and the outlook for mergers and acquisitions.

  • 'Poison Pill' inventor targets activism Friday, 28 Mar 2014 | 7:34 AM ET
    'Poison Pill' inventor targets activism

    Activism in the long-term is not only bad for shareholders but also bad for the economy as a whole, says Martin Lipton, Wachtell, Lipton, Rosen & Katz, expressing his views on shareholder activism. Also Lipton shares his thoughts on the two categories of hedge fund activism.

  • Your guide to understanding 4 mega-deals Friday, 28 Mar 2014 | 6:30 AM ET
    Your guide to understanding 4 mega-deals

    It's been a robust 12 months of mergers and buyouts. Here's an inside look at four high-profile deals from Facebook-WhatsApp to Warren Buffett's involvement with Heinz.

  • Market doesn't like FB's Oculus purchase Wednesday, 26 Mar 2014 | 4:17 PM ET
    Market doesn't like FB's Oculus purchase

    Discussing Facebook's decision to purchase virtual reality technology company Oculus VR for $2 billion, with Dennis Berman, The Wall Street Journal.

  • Facebook's Zuckerberg thinks in decades: Pro Wednesday, 26 Mar 2014 | 2:06 PM ET
    Facebook's Zuckerberg thinks in decades: Pro

    Discussing Facebook's decision to purchase virtual reality technology company Oculus for $2 billion, with Mike Isaac, Re/code senior editor.

  • Facebook's Oculus purchase 'brilliant' Wednesday, 26 Mar 2014 | 1:18 PM ET
    Facebook's Oculus purchase 'brilliant'

    Facebook purchased virtual reality technology company Oculus for $2 billion. Stephan Paterno, Slated CEO & co-founder, says Mark Zuckerberg is making an "offensive bet."